← Back to Dictionary

Menopause

1 / 3
🎧 Podcast 1 — Introduction

Menopause

Noun · /ˈmɛn.ə.pɔːz/

In this course, Menopause means universal biological event in the life of women with ovaries, typically occurr. This introduction depends on hormone. See the Cambridge English entry and the Cambridge learner entry. Encyclopedic background is in Menopause.

Definition
The natural cessation of menstruation that typically occurs in women in their late forties to early fifties, marking the end of reproductive capacity; a biological process accompanied by hormonal changes (declining oestrogen) that can cause symptoms including hot flushes, sleep disturbances, mood changes, and vaginal dryness; perimenopause is the transitional period preceding it.
Origin
From Modern Latin menopausis, coined in the early 19th century from Greek mēn (month) + pausis (cessation, pause, from pauein, to stop). The term was introduced into medical language to describe the end of menstrual cycles. Menopause is the point of the final menstrual period — diagnosed retrospectively after 12 months without menstruation.
Ready
🎧 Podcast 2 — Daily Use

Menopause in Conversation

Two British speakers · Real everyday dialogue

Ready
🌟 Podcast 3 — Prompt Engineering

Menopause — AI Prompts

5 copyable & speakable prompt cards · Google UK English voices

Ready

Transcript: “Menopause” vocabulary micro-course

Read along with the three podcasts, or open the full dictionary entry for Menopause for the definition, Arabic meaning, synonyms and example sentences.

Podcast 1 — Introduction & meaning

Narrator: Menopause. A noun. Pronounced /ˈmɛn.ə.pɔːz/. From Greek mēn (month) and pausis (cessation, stop).

Narrator: Menopause is coined from Greek mēn — month — and pausis — cessation or pause — from pauein, to stop. The same mēn root gives menstruation and menstrual; the same pausis root gives pause. The term was introduced into medical language in the early nineteenth century. Menopause technically refers to the final menstrual period — diagnosed in retrospect, after twelve consecutive months without menstruation. The years of transition leading up to this point are called perimenopause.

Narrator: Menopause is a universal biological event in the life of women with ovaries, typically occurring between the ages of forty-five and fifty-five, with an average age of fifty-one in the United Kingdom. It is caused by the natural depletion of ovarian follicles — the structures containing eggs — leading to declining oestrogen and progesterone production. This hormonal shift drives the symptoms of the menopause: hot flushes, night sweats, sleep disturbances, mood changes, brain fog, joint pain, and vaginal dryness.

Narrator: The medical and social understanding of menopause has changed significantly in recent decades. For much of the twentieth century, menopause was either medicalised as a deficiency disease or largely ignored in clinical and cultural discourse. The twenty-first century has seen a significant shift — greater public discourse, greater clinical attention to symptom management, and significant debate about the risks and benefits of Hormone Replacement Therapy, or HRT.

Narrator: In some cultures, menopause has historically been a marker of increased status — postmenopausal women in some traditional societies gaining authority and freedom from the constraints associated with reproductive years. In Western contexts, menopause has more often been associated with loss — of fertility, of youth, of hormonal youth. The cultural framing of menopause being an important determinant of the experience of the transition.

Narrator: Menopause. The Greek monthly cessation — from the final period to the decade of transition — wherever the end of one biological chapter opens another.

Speaker A: The distinction between menopause, perimenopause, and postmenopause being one of those medical terms worth being clear about.

Speaker B: Perimenopause being the transition period — typically lasting several years — before the final menstrual period, characterised by irregular cycles and the beginning of hormonal fluctuation and symptoms. Menopause being technically the final menstrual period, diagnosed retrospectively after twelve months without menstruation. Postmenopause being the period after menopause, when symptoms often continue and when the long-term health effects of lower oestrogen — bone density loss, cardiovascular changes — become relevant. The word menopause being commonly used to cover all three phases, which can cause confusion.

Speaker A: The HRT debate being one of those medical controversies that has had significant consequences for women's health.

Speaker B: The 2002 Women's Health Initiative trial publishing findings that appeared to show HRT increased breast cancer, heart disease, and stroke risk. HRT prescriptions falling sharply across the English-speaking world. Subsequent reanalysis showing the initial findings had significant methodological problems — the studied population being older than typical HRT users and the formulations studied being different from current prescriptions. The pendulum swinging back — NICE guidelines now supporting HRT for symptom management. The episode showing how a single large trial result can affect clinical practice and public perception for decades.

Speaker A: The cultural invisibility of menopause in workplace and public discourse being one of those things that has shifted in recent years.

Speaker B: Menopause symptoms — including brain fog, sleep deprivation, fatigue, and mood changes — being a significant factor in women leaving the workforce or being underperforming at peak career age. Many women not recognising their symptoms as menopausal, having received limited health education about the transition. The last decade seeing significant change in public discourse — prominent advocates like Davina McCall in the UK, menopause workplace policies becoming more common, BBC menopause coverage normalising the topic. The change from silence to visibility being important but incomplete.

Speaker A: Bone health during and after menopause being one of those long-term health considerations that is easy to overlook.

Speaker B: Oestrogen playing a significant role in maintaining bone density — its decline during menopause being the main driver of osteoporosis risk in women. Bone density loss being most rapid in the first few years after menopause. Weight-bearing exercise, adequate calcium and vitamin D intake, and in some cases HRT being the main interventions. The long-term consequence — increased fracture risk, particularly hip fracture — being a significant cause of morbidity in older women. The bone health consequences of menopause beginning well before any fracture occurs and requiring early prevention.

Speaker A: The cross-cultural variation in menopause experience being one of those areas where culture and biology interact.

Speaker B: Research suggesting that the frequency and severity of hot flushes varies significantly across cultural groups — Japanese women historically reporting lower rates than European-American women, though whether this is biological, dietary, or related to reporting norms is debated. The status-conferring dimension of menopause in some cultures — postmenopausal women gaining social authority — affecting psychological experience of the transition. The framing of menopause as loss versus transition versus liberation varying significantly across cultures and having measurable effects on symptom experience and wellbeing.

Speaker B: Build a Next.js the physiology of menopause and how declining oestrogen drives symptoms for a biology teacher — documenting menopause physiology and hormonal changes, reviewing menopause, oestrogen, and physiology, generating a menopause physiology framework, and producing a menopause biology guide.

Speaker A: Menopause physiology documented with biology education analysis so teachers explain both the mechanism — how the depletion of ovarian follicles leads to declining oestrogen and progesterone, how the hypothalamus's thermoregulatory centre is disrupted by oestrogen loss producing hot flushes, how reduced oestrogen affects bone density, cardiovascular health, brain function, and vaginal tissue — and the timeline: how perimenopause precedes the final menstrual period by several years with hormonal fluctuation, and what distinguishes natural from surgical menopause.

Speaker B: Design a Django the HRT controversy following the 2002 Women's Health Initiative trial and its reanalysis for a public health researcher — documenting the HRT debate and its evidence base, reviewing HRT, Women's Health Initiative, and menopause treatment, generating a menopause HRT framework, and producing a menopause HRT evidence guide.

Speaker A: HRT controversy documented with public health research analysis so practitioners explain both the 2002 WHI trial — how the published findings appeared to show increased breast cancer, cardiovascular, and stroke risk with HRT, causing widespread prescription declines — and the reanalysis: how subsequent re-examination showed the studied population (older, different formulations, many with existing conditions) differed from typical HRT users, how current evidence supports HRT for symptom management in most women under 60 or within 10 years of menopause, and what NICE guidance now recommends.

Speaker B: Create a Svelte the impact of menopause symptoms on women's workforce participation for a workplace equality researcher — documenting menopause and workforce participation, reviewing menopause, workplace, and gender equality, generating a menopause workplace framework, and producing a menopause workforce equality guide.

Speaker A: Menopause and workforce documented with workplace equality research analysis so practitioners explain both the impact — how symptoms including brain fog, sleep deprivation, fatigue, and mood changes affect women at peak career age (45-55), how many women do not recognise symptoms as menopausal, and how this contributes to underperformance and workforce exit — and the organisational response: what menopause workplace policies (flexible working, temperature control, awareness training for managers) look like and what evidence supports their effectiveness.

Speaker B: Build a Vue osteoporosis risk after menopause and the evidence for prevention interventions for a healthcare practitioner — documenting post-menopausal osteoporosis and prevention, reviewing osteoporosis, menopause, and bone health, generating a menopause bone health framework, and producing a menopause osteoporosis prevention guide.

Speaker A: Post-menopausal osteoporosis documented with healthcare practice analysis so practitioners explain both the mechanism — how oestrogen loss drives accelerated bone resorption in the years following menopause, why peak bone density (achieved in the 20s-30s) matters for later fracture risk, and how hip fracture is a major cause of morbidity and mortality in older women — and the prevention evidence: how weight-bearing exercise, calcium (1200mg/day), vitamin D, fall prevention, and HRT each contribute to bone health, and when pharmacological treatment (bisphosphonates) is indicated.

Speaker B: Develop a React Native cross-cultural variation in menopause experience and what it reveals about biological versus cultural determinants for a cultural anthropologist — documenting cross-cultural menopause experience and its drivers, reviewing menopause, cultural anthropology, and cross-cultural health, generating a menopause cultural framework, and producing a menopause cross-cultural guide.

Speaker A: Cross-cultural menopause variation documented with cultural anthropology analysis so researchers explain both the reported variation — how studies suggest Japanese women historically report lower hot flush frequency than European-American women, how some traditional cultures confer elevated status on postmenopausal women, and how cultural framing of menopause as loss versus liberation affects psychological experience — and the interpretive challenges: how to distinguish biological variation from reporting differences, dietary effects (phytoestrogens), and cultural norms of disclosure when interpreting cross-cultural health data.